Company profile
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune diseases
- Industry
- Biotechnology Research
- Employees
- 191
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2017
- LinkedIn followers
- 18,517
- Office locations
- 1
Cabaletta Bio company summary
Cabaletta Bio is a company in the Biotechnology Research industry, headquartered in Philadelphia, Pennsylvania, founded in 2017. On LinkedIn the company has around 191 employees and 18,517 followers. Its listed specialties include cell therapy, biotech, immunology, autoimmune, rheumatology.
What technology does Cabaletta Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Cabaletta Bio
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA™ platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA.
Specialties
Where is Cabaletta Bio located?
Cabaletta Bio lists 1 location.
Compare companies similar to Cabaletta Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Cabaletta Bio cabalettabio.com | Biotechnology Research | 191 | 2017 | Philadelphia, Pennsylvania |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Cabaletta Bio
What does Cabaletta Bio do?
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA™ platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA.
How many employees does Cabaletta Bio have?
Cabaletta Bio has around 191 employees on LinkedIn.
Where is Cabaletta Bio headquartered?
Cabaletta Bio is headquartered in Philadelphia, Pennsylvania.
When was Cabaletta Bio founded?
Cabaletta Bio was founded in 2017.
Build a lead list from companies like Cabaletta Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.